CVE-2019-5024A restricted environment escape vulnerability exists in the “kiosk mode” function of Capsule Technologies SmartLinx Neuron 2 medical information collection devices running versions 9.0.3 or lower.
Updated under an hour ago ()
Does this affect you?
It affects Capsule Technologies SmartLinx Neuron 2 and 1 other product. Add what you run to find out whether that includes you.
EPSS puts the chance of exploitation in the next 30 days at 0.47%, higher than 39% of scored CVEs.
Do this next
Free account, 1 product
A restricted environment escape vulnerability exists in the “kiosk mode” function of Capsule Technologies SmartLinx Neuron 2 medical information collection devices running versions 9.0.3 or lower. A specific series of keyboard inputs can escape the restricted environment, resulting in full administrator access to the underlying operating system. An attacker can connect to the device via USB port with a keyboard or other HID device to trigger this vulnerability.
- CVSS
- 7.6 HIGH (v3.0, CNA)CVSS:3.0/AV:P/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H
- Weakness (CWE)
- CWE-693
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- 0.47% (percentile 39)
- Assigned by
- talos
- NVD analysis
- Modified
- Record last updated
- Aug 4, 2024
- First seen by InfoSec Signals
- Oct 12, 2026
Affected products
Capsule Technologies Capsule Technologies SmartLinx Neuron 2 capsule_technologies:smartlinx_neuron_2 (from the name) | 9.0.3 or lower | CNA record |
capsuletech smartlinx_neuron_2_firmware capsuletech:smartlinx_neuron_2_firmware | through 9.0.3 | NVD |
References
- https://talosintelligence.com/vulnerability_reports/TALOS-2019-0785x-refsource-confirm, third-party-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.